Fairfax Northern Virginia Hem/Onc

Fairfax, Virginia 22031

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Metastatic Breast Cancer, Non-small Cell Lung Cancer

Studies at this site

• Phase II of Neoadjuvant and Adjuvant Capmatinib in NSCLC — Stopped early
• Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer — Completed
• Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer — Completed